<DOC>
	<DOCNO>NCT02774850</DOCNO>
	<brief_summary>Treatment pediatric acute myeloid leukemia ( AML ) involve intensive chemotherapy regimens result period profound neutropenia leave patient susceptible severe infectious complication . Infectious complication lead cause treatment related mortality among AML patient , little clinical data inform whether management neutropenia post AML chemotherapy occur outpatient inpatient setting . The primary objective study compare clinical effectiveness outpatient versus inpatient management neutropenia child AML .</brief_summary>
	<brief_title>Home Away From Home - Medical Outcomes</brief_title>
	<detailed_description>This bidirectional observational cohort study . Participants patient 18 year age young diagnosis receive receive chemotherapy AML fifteen participate pediatric hospital across United States . There study intervention ; medical record abstraction study . Investigators abstract subject medical record data study period order study clinical outcome include occurrence bacteremia time start next course chemotherapy regimen , relation neutropenia management strategy .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Bacteremia</mesh_term>
	<criteria>1 . Males females 18 year age young diagnosis . 2 . Receipt plan receipt AML chemotherapy January 1 , 2012 December 31 , 2018 . There exclusion criterion protocol . All patient meet inclusion criterion contribute data .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Pediatric</keyword>
	<keyword>Neutropenia Management</keyword>
	<keyword>Acute Myeloid Leukemia</keyword>
	<keyword>Chart Abstraction</keyword>
	<keyword>Chemotherapy</keyword>
</DOC>